These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4054423)

  • 1. Reduction of extracellular potassium ferricyanide by transmembrane NADH: (acceptor) oxidoreductase of human erythrocytes.
    Schipfer W; Neophytou B; Trobisch R; Groiss O; Goldenberg H
    Int J Biochem; 1985; 17(7):819-23. PubMed ID: 4054423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin control of a transplasma membrane NADH dehydrogenase in erythrocyte membranes.
    Crane FL; Crane HE; Sun IL; MacKellar WC; Grebing C; Löw H
    J Bioenerg Biomembr; 1982 Dec; 14(5-6):425-33. PubMed ID: 6761340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A transmembranous NADH-dehydrogenase in human erythrocyte membranes.
    Grebing C; Crane FL; Löw H; Hall K
    J Bioenerg Biomembr; 1984 Dec; 16(5-6):517-33. PubMed ID: 6537435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for the existence of two NADH-ferricyanide reductases in human erythrocyte membranes [proceedings].
    Agutter PS; Dallas JM; Newman P; Kadlubowski M
    Biochem Soc Trans; 1980 Jun; 8(3):326. PubMed ID: 7399071
    [No Abstract]   [Full Text] [Related]  

  • 5. Purification and properties of human erythrocyte membrane NADH-cytochrome b5 reductase.
    Kitajima S; Yasukochi Y; Minakami S
    Arch Biochem Biophys; 1981 Aug; 210(1):330-9. PubMed ID: 7294831
    [No Abstract]   [Full Text] [Related]  

  • 6. An assessment of the value of the crypticity of NADH-ferricyanide reductase as an indicator of structural integrity of human erythrocyte membranes [proceedings].
    Stewart CA; Agutter PS; Kadlubowski M
    Biochem Soc Trans; 1980 Jun; 8(3):325. PubMed ID: 7399070
    [No Abstract]   [Full Text] [Related]  

  • 7. An ascorbate-mediated transmembrane-reducing system of the human erythrocyte.
    Orringer EP; Roer ME
    J Clin Invest; 1979 Jan; 63(1):53-8. PubMed ID: 216708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma membrane nadh dehydrogenase and Ca2+-dependent potassium transport in erythrocytes of several animal species.
    Miner C; López-Burillo S; García-Sancho J; Herreros B
    Biochim Biophys Acta; 1983 Jan; 727(2):266-72. PubMed ID: 6404302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular flavonoids as electron donors for extracellular ferricyanide reduction in human erythrocytes.
    Fiorani M; De Sanctis R; De Bellis R; Dachà M
    Free Radic Biol Med; 2002 Jan; 32(1):64-72. PubMed ID: 11755318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human erythrocyte NADH: (acceptor) oxidoreductase. Kinetic properties and competitive substrate inhibition by ferricyanide.
    Wang CS
    Biochim Biophys Acta; 1980 Nov; 616(1):22-9. PubMed ID: 7437448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ascorbate-dependent electron transfer across the human erythrocyte membrane.
    May JM; Qu ZC
    Biochim Biophys Acta; 1999 Sep; 1421(1):19-31. PubMed ID: 10561468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ascorbate is the major electron donor for a transmembrane oxidoreductase of human erythrocytes.
    May JM; Qu ZC; Whitesell RR
    Biochim Biophys Acta; 1995 Sep; 1238(2):127-36. PubMed ID: 7548127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of a NADH dehydrogenase in the human erythrocyte by beta-adrenergic agonists: possible involvement of a G protein in enzyme activation.
    Marques F; Bicho MP
    Biol Signals; 1997; 6(2):52-61. PubMed ID: 9266092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ascorbic acid recycling enhances the antioxidant reserve of human erythrocytes.
    May JM; Qu ZC; Whitesell RR
    Biochemistry; 1995 Oct; 34(39):12721-8. PubMed ID: 7548025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ascorbate recycling in human erythrocytes: role of GSH in reducing dehydroascorbate.
    May JM; Qu ZC; Whitesell RR; Cobb CE
    Free Radic Biol Med; 1996; 20(4):543-51. PubMed ID: 8904295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 13C-NMR studies of transmembrane electron transfer to extracellular ferricyanide in human erythrocytes.
    Himmelreich U; Kuchel PW
    Eur J Biochem; 1997 Jun; 246(3):638-45. PubMed ID: 9219520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ferricyanide reduction by human erythrocytes in the presence of carriers of redox equivalents across the membrane].
    Tsybyshev VP; Kuznetsov AN
    Izv Akad Nauk SSSR Biol; 1988; (1):64-74. PubMed ID: 3351101
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bioluminescence study of NAD-dependent dehydrogenase and isoenzyme activity of human blood using soluble and immobilized bacterial luciferase].
    Ismailov AD; Danilov VS; Egorov NS
    Dokl Akad Nauk SSSR; 1983; 270(5):1239-42. PubMed ID: 6884193
    [No Abstract]   [Full Text] [Related]  

  • 19. [Potentiometric study of redox systems of human erythrocytes using potassium ferricyanide].
    Balmukhanov BS; Zamula SV; Ataullakhanov FI
    Biokhimiia; 1980 May; 45(5):945-9. PubMed ID: 7378513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of erythrocyte plasma membrane NADH dehydrogenase by nucleotides and uncouplers.
    Howland JL; Osrin D; Donatelli M; Theofrastous JP
    Biochim Biophys Acta; 1984 Dec; 778(3):400-4. PubMed ID: 6509043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.